| Study name |
A clinical trial to study the effects of two drugs dydrogesterone and micronized progesterone in pregnant women with threatened abortion |
| Methods |
2‐arm active‐controlled randomised trial |
| Participants |
Women aged from 20 to 35 years, with a singleton intrauterine live pregnancy, gestational age less than 12 weeks and presenting with threatened abortion. The exclusion criteria includes history of recurrent miscarriage (defined as at least 3 consecutive spontaneous miscarriages), history of cervical surgery, heavy vaginal bleeding requiring surgical intervention, any uterine anomalies, and any associated medical and surgical illness. |
| Interventions |
40 mg dydrogesterone stat followed by 10 mg BD till 14 weeks of gestation versus 200 mg progesterone twice daily till 14 weeks of gestation |
| Outcomes |
Miscarriage before 20 weeks of gestation; live birth rate; period of gestational age at delivery; birthweight at delivery; antepartum haemorrhage; pre‐eclampsia |
| Starting date |
12‐Oct‐2020 |
| Contact information |
saicharishma1544@gmail.com |
| Notes |
|
